PATENT CLAIM ANALYSIS

Application Number: 16075409
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["544", "316000"]

Abstract:
The present invention provides a compound having TrkA inhibitory activity, or a pharmaceutically acceptable salt thereof. The present invention relates to a compound represented by Formula (I): wherein ═X is ═O or the like, R 5  and R 5A  are hydrogen atoms or the like, -A- is —NR 1 — or the like, B is substituted or unsubstituted aromatic carbocyclyl or the like, R 1  is substituted or unsubstituted alkyl or the like, R 2  is a hydrogen atom or the like, —W— is —CH 2 — or the like, —W A — is —CH 2 — or the like, R 13  is substituted or unsubstituted aromatic carbocyclyl or the like, R 14  is substituted or unsubstituted aromatic heterocyclyl or the like, R 15  is substituted or unsubstituted alkyl or the like, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the same.

Claim (Index 11):
The compound according to  claim 2 ,\n wherein R 5  and R 5A  are hydrogen atoms, and \u2550X is \u2550O, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 96.0
- Lexical Diversity: 2.5873
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15501749', '15741875', '16061155', '14387387', '15557992']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8293031640179542
- 35 USC 102 Novelty (BERT): 0.6187129018209915
- Combined Prediction Score: 0.808244137798258
- Mean Citation Score: 532.0969520000001
- Max Citation Score: 581.6987
- Similarity Product: 507.4155153879285

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test